IDiyas

For the Inventor, By the Inventor

Mishima, Japan

Tadashiro Fujii

USPTO Granted Patents = 14

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 91(Granted Patents)


Location History:

  • Mishima, JA (1976)
  • Shizuoka, JA (1976)
  • Mishima, JP (1979 - 1983)
  • Shizuoka, JP (1983 - 1986)

Company Filing History:

goldMedal12 out of 95 
 
Toyo Jozo Kabushiki Kaisha
 patents
silverMedal2 out of 48 
 
Toyo Jozo Company, Ltd.
 patents
bronzeMedal1 out of 191 
 
Sagami Chemical Research Center
 patents
where one patent can have more than one assignee

Years Active: 1976-1986

Loading Chart...
14 patents (USPTO):Explore Patents
1. 4613666 - Neplanocin A derivatives (1986-09-23),
2. 4423218 - Antibiotic neplanocin A (1983-12-27),
3. 4384041 - Assay method of enzyme activity (1983-05-17),
4. 4349667 - Aminoglycoside antibiotic G-367-2 (1982-09-14),
5. 4321376 - Neplanocin-B and -F (1982-03-23),
6. 4297486 - Aminoglycoside antibiotic G-367-1 and method for the production thereof (1981-10-27),
7. 4291021 - Novel macrolide antibiotics and preparation thereof (1981-09-22),
8. 4288429 - Antibiotic planothiocins (1981-09-08),
9. 4287345 - Polyfunctional disulfide compounds having S--S exchange reactivity (1981-09-01),
10. 4258193 - Disulfide derivatives having S--S exchange reactivity (1981-03-24),
11. 4237267 - Disulfide compounds of a carrier, having S--S exchange reactivity (1980-12-02),
12. 4137406 - Cephalosporins having a sulfur containing functional group in the (1979-01-30),
13. 3960662 - Process for the production of 7-amino-cephem compounds (1976-06-01),
14. 3935193 - Diacyl penicillins and methods for their production (1976-01-27),

Title: **The Innovative Contributions of Tadashiro Fujii**

Introduction

Tadashiro Fujii, an accomplished inventor based in Mishima, Japan, has made significant strides in the field of pharmaceuticals. With a total of 14 patents to his name, his innovative work focuses primarily on antibiotic compounds and their derivatives, aimed at treating various medical conditions effectively.

Latest Patents

Fujii's latest patents include the creation of Neplanocin A derivatives, which possess a specific formula designed to inhibit the growth of L 5178 Y cells. These compounds hold the promise of serving as effective antitumor agents, offering activity levels comparable or superior to neplanocin A itself. Additionally, he has developed methods for producing antibiotic neplanocin A through the cultivation of Ampullariella sp. A 11079 FERM-P No. 4494, showcasing his dedication to advancing antibiotic therapies.

Career Highlights

Throughout his career, Fujii has been associated with prominent companies in the industry, namely Toyo Jozo Kaushiki Kaisha and Toyo Jozo Company, Ltd. These experiences have enriched his knowledge and skill set, allowing him to dive deep into research and product development that has shaped his inventive contributions.

Collaborations

Fujii's work has also been enhanced through collaborations with noteworthy professionals such as Naoki Muto and Masaru Otani. Working alongside these colleagues has fostered an environment of creativity and shared expertise, enriching the innovation process and leading to the successful development of his patents.

Conclusion

Tadashiro Fujii's innovative spirit and commitment to advancing medical science through his patents underscore the essential role of inventors in improving health outcomes. His work in developing new antibiotics and antitumor agents will undoubtedly influence the future of pharmaceutical research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…